BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 18821526)

  • 1. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
    Skvortsova I; Skvortsov S; Stasyk T; Raju U; Popper BA; Schiestl B; von Guggenberg E; Neher A; Bonn GK; Huber LA; Lukas P
    Proteomics; 2008 Nov; 8(21):4521-33. PubMed ID: 18821526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D; Shaw K; Jazayeri J; Leedman PJ
    Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
    Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
    Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S; Wang X; Ng CF; Chen S; Chan FL
    Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines.
    Chow L; Rezmann L; Imamura K; Wang L; Catt K; Tikellis C; Louis WJ; Frauman AG; Louis SN
    Prostate; 2008 May; 68(6):651-60. PubMed ID: 18288685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.
    Huang D; Liu X; Plymate SR; Idowu M; Grimes M; Best AM; McKinney JL; Ware JL
    Oncogene; 2004 Sep; 23(41):6881-9. PubMed ID: 15300238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activation of the 41- and 43-kDa mitogen-activated protein (MAP) kinases in the progression of prostate cancer to an androgen-independent state.
    Oka H; Chatani Y; Kohno M; Kawakita M; Ogawa O
    Int J Urol; 2005 Oct; 12(10):899-905. PubMed ID: 16323984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.
    Aloy MT; Hadchity E; Bionda C; Diaz-Latoud C; Claude L; Rousson R; Arrigo AP; Rodriguez-Lafrasse C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):543-53. PubMed ID: 17980509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
    Pang B; Zhang H; Wang J; Chen WZ; Li SH; Shi QG; Liang RX; Xie BX; Wu RQ; Qian XL; Yu L; Li QM; Huang CF; Zhou JG
    Prostate; 2009 Aug; 69(11):1176-87. PubMed ID: 19415690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells.
    Yu CH; Kan SF; Pu HF; Jea Chien E; Wang PS
    Cancer Sci; 2008 Dec; 99(12):2467-76. PubMed ID: 19037992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma.
    Hagan M; Yacoub A; Dent P
    Clin Cancer Res; 2004 Sep; 10(17):5724-31. PubMed ID: 15355899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor and invasion in prostate cancer.
    Hara T; Miyazaki H; Lee A; Tran CP; Reiter RE
    Cancer Res; 2008 Feb; 68(4):1128-35. PubMed ID: 18281488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
    Davoodpour P; Landström M; Welsh M
    BMC Cancer; 2007 Aug; 7():161. PubMed ID: 17697368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
    Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of irradiation on the [Methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3.
    Holzapfel K; Müller SA; Seidl C; Grosu AL; Schwaiger M; Senekowitsch-Schmidtke R
    Strahlenther Onkol; 2008 Jun; 184(6):319-24. PubMed ID: 18535808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.
    McCarthy HO; Coulter JA; Worthington J; Robson T; Hirst DG
    J Gene Med; 2007 Jun; 9(6):511-20. PubMed ID: 17471586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular zinc and zinc-citrate, acting through a putative zinc-sensing receptor, regulate growth and survival of prostate cancer cells.
    Dubi N; Gheber L; Fishman D; Sekler I; Hershfinkel M
    Carcinogenesis; 2008 Sep; 29(9):1692-700. PubMed ID: 18310092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.